{
  "trial_id": "NCT03477240",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "approximately 1-2 weeks prior to her expected date of follow up, for a preliminary conversation and invited to participate in the study.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "After verbal telephonic consent is obtained, she will be interviewed by the clinical research nurse using the format of the prepared proforma (Form A) regarding symptoms suggestive of disease recurrence as well as treatment induced toxicity.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "When the patient reports to the OPD the next week for scheduled physical follow up, the nurse completes the consenting process by taking a short written informed consent.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "In addition at the physical visit, information regarding the acceptability of nurse-led telephonic follow-up to the patient and the financial impact of physical follow- up will be collected using a structured format (Form C).",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Contactable by telephone.",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "Patients with Stage III disease treated with palliative intent with once monthly radiotherapy.",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "Early stage cervical cancer patients who underwent Wertheims hysterectomy and who have completed adjuvant radiochemotherapy due to high-risk factors.",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "Metastatic cervical cancers.",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "Patients who are unable to comprehend the questions or dialogue over telephone by medical staff.",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "Patients who seem unreliable for follow up.",
      "label": "triggers",
      "evidence": "none"
    }
  ],
  "notes": "16-year-old girl recently diagnosed with myasthenia gravis, class IIa. She complains of diplopia and weakness affecting in her upper extremities.",
  "_meta": {
    "topic_id": "72",
    "trial_id": "NCT03477240",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}